| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma
|
Yazbeck, Victor
|
|
2018
|
18 |
9 |
p. 569-575.e1
|
article
|
| 2 |
Bone Health and Survival in Women With Multiple Myeloma
|
Rosko, Ashley E.
|
|
2018
|
18 |
9 |
p. 597-602.e1
|
article
|
| 3 |
Editorial Board
|
|
|
2018
|
18 |
9 |
p. A4-A5
|
article
|
| 4 |
Hodgkin Lymphoma With Multiple Autoimmune Disorders: Case Report and Review of the Literature
|
Grover, Natalie S.
|
|
2018
|
18 |
9 |
p. e365-e368
|
article
|
| 5 |
Hypomethylating Agents-associated Infections—Systematic Review and Meta-analysis of Randomized Controlled Trials
|
Shargian-Alon, Liat
|
|
2018
|
18 |
9 |
p. 603-610.e1
|
article
|
| 6 |
Identifying Tyrosine Kinase Inhibitor Nonadherence in Chronic Myeloid Leukemia: Subanalysis of TAKE-IT Pilot Study
|
Leader, Avi
|
|
2018
|
18 |
9 |
p. e351-e362
|
article
|
| 7 |
Molecular Markers and Prognosis of Myelofibrosis in the Genomic Era: A Meta-analysis
|
Lee, Yen-Chien
|
|
2018
|
18 |
9 |
p. 558-568
|
article
|
| 8 |
Multiple Myeloma Patients Ineligible for Randomized Controlled Trials Have Poorer Outcomes Irrespective of Treatment
|
Malecek, Mary-Kate
|
|
2018
|
18 |
9 |
p. e363-e364
|
article
|
| 9 |
Patient-Reported Outcomes Data From REVEAL at the Time of Enrollment (Baseline): A Prospective Observational Study of Patients With Polycythemia Vera in the United States
|
Mesa, Ruben
|
|
2018
|
18 |
9 |
p. 590-596
|
article
|
| 10 |
Prevalence of Monoclonal Gammopathy of Undetermined Significance in India—A Hospital-based Study
|
Gupta, Ritu
|
|
2018
|
18 |
9 |
p. e345-e350
|
article
|
| 11 |
Sustained Remission of γδ T-Cell Lymphoma by Graft-Versus-Lymphoma Effect That Relapsed Early After Cord Blood Transplantation
|
Ichikawa, Satoshi
|
|
2018
|
18 |
9 |
p. e369-e372
|
article
|
| 12 |
Table of Contents
|
|
|
2018
|
18 |
9 |
p. A6, A12-A13
|
article
|
| 13 |
The Multiple Myeloma Drug Pipeline—2018: A Review of Small Molecules and Their Therapeutic Targets
|
Abramson, Hanley N.
|
|
2018
|
18 |
9 |
p. 611-627
|
article
|
| 14 |
Treatment of Older Patients With Newly Diagnosed AML Unfit for Traditional Therapy
|
Burnett, Alan K.
|
|
2018
|
18 |
9 |
p. 553-557
|
article
|
| 15 |
Trends in the Risks of Secondary Cancers in Patients With Hodgkin Lymphoma
|
Kumar, Vivek
|
|
2018
|
18 |
9 |
p. 576-589.e1
|
article
|
| 16 |
Venetoclax in Combination With Bortezomib, Dexamethasone, and Daratumumab for Multiple Myeloma
|
Rahbari, Kian J.
|
|
2018
|
18 |
9 |
p. e339-e343
|
article
|
Journal description